Skip to Main Content

Paper Details

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells.
Mol Cancer Ther
16
2021
4-1BB costimulatory domain, Anti-CD19, B-ALL, B-cell acute lymphoblastic leukemia, B-cell malignancies, CAR, CAR T cells, CD19, CD3 signaling domain, CD8 transmembrane domain, Humanized, IFN, IL6, NALM6, NALM6 tumor cells, Novel Humanized Anti-CD19 CAR T Cells, TNF, anti, anti-CD19, antigen, chimeric, cytokine, cytokine release syndrome, h1CAR19, h1CAR19-8BB, h1CAR19-8BB T cells, humanized, humanized anti-CD19 CAR, humanized anti-CD19 CAR T cells, humanized anti-CD19 scFv, mCAR19, mCAR19-8BB, mCAR19-8BB T cells, monocytes, murine, murine FMC63 mAb, murine scFv, patients, scFv, single-chain variable fragment, tumor
Author NameAffiliation
Sushant KumarHomi Bhabha National Institute
David F StroncekCenter for Cancer Research, National Cancer Institute, National Institutes of Health
David F StroncekCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 3

Datasets